Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Drug Therapy for Patients With Hepatitis C
This study has been completed.
Study NCT00001729   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Hepatitis C
Fibrosis
Hemolytic Anemia
Additional conditions recognized in this trial
Anemia
Anemia, Hemolytic
Hepatitis
Hepatitis C
Hepatitis C, Chronic
Hepatitis, Chronic
More general conditions related to this trial
Digestive System Diseases
Flaviviridae Infections
Hematologic Diseases
Hepatitis, Viral, Human
Liver Diseases
Pathologic Processes
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
Ribavirin
Additional drug interventions recognized in this trial
Interferon-alpha
More general drug interventions related to this trial
Anti-Infective Agents
Antimetabolites
Antiviral Agents
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services